Currently out of the existing stock ratings of Yuan Zhi, 4 are a HOLD (16%), 21 are a BUY (84%).

Yuan Zhi

Work Performance Price Targets & Ratings Chart

Analyst Yuan Zhi works at B. RILEY with a stock forecast success ratio of 44.9% fulfilled within 63.57 days on average.

Yuan Zhi’s has documented 49 price targets and ratings displayed on 7 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on CYRX, Cryoport at 03-May-2024.

Wall Street Analyst Yuan Zhi

Analyst best performing recommendations are on FUSN (FUSION PHARMACEUTICALS ).
The best stock recommendation documented was for FUSN (FUSION PHARMACEUTICALS ) at 10/3/2023. The price target of $13 was fulfilled within 140 days with a profit of $9.78 (303.73%) receiving and performance score of 21.69.

Average potential price target upside

AZTA Azenta BLFS BioLife Solutions CYRX Cryoport ISEE IVERIC bio FUSN Fusion Pharmaceuticals  AMAM Ambrx Biopharma . American Depositary Shares NGM NGM Biopharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

69

$18.13 (35.64%)

75

9 days ago

3/19 (15.79%)

$16.49 (31.40%)

92

60

$9.13 (17.95%)

55

1 months 14 days ago

3/5 (60%)

$1.83 (3.15%)

6

Buy

79

$28.13 (55.30%)

68

3 months 17 days ago

0/5 (0%)

$12.87 (19.46%)

Hold

55

$-10.11 (-15.53%)

45

6 months 5 days ago

6/8 (75%)

$0.55 (1.01%)

71

70

1 years 8 days ago

4/8 (50%)

$26.01 (59.13%)

208

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yuan Zhi is most bullish on?

Potential upside of $28.13 has been obtained for AZTA (AZENTA)

Which stock is Yuan Zhi is most reserved on?

Potential downside of -$0 has been obtained for AMAM (AMBRX BIOPHARMA . AMERICAN DEPOSITARY SHARES)

What Year was the first public recommendation made by Yuan Zhi?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?